Sub Banner Image

Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction

Market Impact

Vandana Singh

·

August 11, 2025

·

Benzinga

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.